Notice of Correction Regarding Eligibility of Foreign Components for PAR-16-301 "Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24)"

Notice Number: NOT-HL-16-330

Key Dates
Release Date:  June 14, 2016

Related Announcements
NOT-HL-16-337
PAR-16-301

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

On May 31, 2016, the NHLBI issued funding Opportunity Announcement PAR-16-301 "Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24)".  This Notice announces a correction to information regarding the eligibility of foreign components.

The following section of the FOA is revised accordingly:

Part 2. Section III. Eligibility Information

 

1. Eligible Applicants

 

Foreign Institutions

Current Language:
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed

Revised Language:
Foreign components, as defined in the NIH Grants Policy Statement, are allowed

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Keary Cope, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0287
Email: copeka@nhlbi.nih.gov